Supplemental Table 1 and 2 from ERK Mutations Confer Resistance to Mitogen-Activated Protein Kinase Pathway Inhibitors
crossref(2023)
摘要
Supplemental Table 1 and 2. Amino acid substitutions for each significantly mutated ERK1/2 nucleotide for the ERK inhibitor screen (Table 1) or the RAF/MEK inhibitor screen (Table 2) and the accompanying resistance phenotype.
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要